VIS-410

N/A

Report date: 2023/11/22 20:04:33

Base Information

Drug NameVIS-410
Drug Alias NameInfluenza virus fusion inhibitor (Visterra)VIS-410
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionInfluenza virus hemagglutinin glycoproteins inhibitors
TargetsInfluenza virus hemagglutinin glycoproteins
Therapy Area/IndicationsInfluenza A virus infectionsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumBulgariaCanada +[20] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVisterra Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVir Biotechnology IncVisterra Inc
Active IndicationsN/A
Inactive IndicationsInfluenza A virus infectionsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A